Omeros - Precio De Mercado

OMER

18.01

Cambio Diario:

0.11%

Anual:

21.73%

Precio Día Año
AcelRx Pharmaceuticals 2.20 0.34 18.28% 10.55%
Adma Biologics 2.09 -0.01 -0.47% -54.47%
Adamas Pharmaceuticals 4.52 -0.01 -0.22% -23.39%
Aerie Pharmaceuticals 14.05 -0.06 -0.43% -41.73%
Alnylam Pharmaceuticals 166.96 1.89 1.14% 39.90%
Alexion Pharmaceuticals 156.83 0.30 0.19% 39.39%
BioMarin Pharmaceutical 83.14 1.85 2.27% -6.72%
Cytokinetics 19.44 -0.36 -1.82% 54.16%
Dynavax Technologies 5.26 0.12 2.33% -14.75%
Five Prime Therapeutics 14.66 -1.28 -8.02% 184.66%
Gilead Sciences 63.35 0.95 1.52% 0.24%
Knight Therapeutics Inc 5.48 0.10 1.86% -32.18%
Heron Therapeutics 17.60 -0.74 -4.03% -23.18%
Intercept Pharmaceuticals 27.86 -1.38 -4.72% -74.73%
Insmed 37.01 -0.27 -0.72% 63.11%
MacroGenics 21.00 0.38 1.84% 81.19%
Mirati Therapeutics 216.06 2.31 1.08% 121.76%
Omeros 18.01 0.02 0.11% 21.73%
Pacira 74.97 -2.19 -2.84% 70.39%
PDL BioPharma 2.47 -0.23 -8.52% -23.05%
Pfizer 36.69 -0.05 -0.14% -9.65%
Regulus Therapeutics 1.19 0.01 0.84% -3.64%
Rockwell Medical 1.22 0.01 0.82% -57.04%
Sangamo BioSciences 16.06 -0.07 -0.43% 81.57%
Sarepta Therapeutics 91.93 2.03 2.26% -29.45%
United Therapeutics 170.54 3.28 1.96% 81.18%
Vertex Pharmaceuticals 226.17 0.30 0.13% -3.96%
Immunic Inc. 18.21 0.19 1.04% 103.66%
Xoma 40.62 1.07 2.68% 70.31%

Precio Día Año
NASDAQ 13071 -40.74 -0.31% 39.70%
Russell 2000 2133 -21.56 -1.00% 25.13%

OMER:US
Bienes
Efectivo Y Equivalentes
El Costo De Ventas
Activos Circulantes
Pasivo Circulante
DEUDA
EBIT
EBITDA
Empleados
Eps Ganancias Por Acción
Capital Y Las Reservas
Beneficio Bruto En Ventas
Los Gastos Financieros De La Deuda
Capital De Préstamo
Capitalización De Mercado
Lngresos Netos
Los Gastos De Explotación
Beneficio Operativo
Capital Social Ordinario
Beneficio Antes De Impuestos
Ingresos Por Ventas
Gastos De Venta Y Administración
Valores
Acreedores Comerciales
Deudores Comerciales